References
- Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev 2016;96:365-408. https://doi.org/10.1152/physrev.00014.2015
- Masoon MQ, Khan A, Awan S, Dar F, Naz S, Naureen G, et al. Comparison of vitamin D replacement strategies with high-dose intramuscular or oral cholecalciferol: a prospective intervention study. Endocr Pract 2015;21:1125-33. https://doi.org/10.4158/EP15680.OR
- Zagzag J, Hu MI, Fisher SB, Perrier ND. Hypercalcemia and cancer: Differential diagnosis and treatment. CA Cancer J Clin 2018;68:377-86. https://doi.org/10.3322/caac.21489
- Pourrashid MH, Dastan F, Salamzadeh J, Eslaminejad A, Edalatifard M. Role of vitamin D replacement on health related quality of life in hospitalized patients with "acute exacerbation of chronic obstructive pulmonary disease". Iran J Pharm Res 2018;17:801-10.
- Medeiros IG, Silva AS, Costa MJ, Persuhn DC, Issa CT, Luna TL, et al. Effect of vitamin D3 supplementation and influence of BsmI polymorphism of the VDR gene of the inflammatory profile and oxidative stress in elderly women with vitamin D insufficiency: Vitamin D3 megadose reduces inflammatory markers. Exp Gerontol 2015;66:10-6. https://doi.org/10.1016/j.exger.2015.03.011
- Malhan M, Peter JS, Lauridsen AL, Ott P, Glerup H, Dahlerup JF. The effect of a single oral megadose of vitamin D provided as either ergocalciferol (D(2)) or cholecalciferol (D(3)) in alcoholic liver cirrhosis. Eur J Gastroenterol Hepatol 2012;24:172-8. https://doi.org/10.1097/MEG.0b013e32834d1755
- Peppone LJ, Ling M, Huston AJ, Reid ME, Janelsins MC, Puzas JE, et al. The effects of high-dose calcitriol and individualized exercise on bone metabolism in breast cancer survivors on hormonal therapy: a phase II feasibility trial. Support Care Cancer 2018;26:2675-83. https://doi.org/10.1007/s00520-018-4094-4
- Diamond TH, Ho KW, Rohl PG, Meerkin M. Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data. Med J Aust 2005;183:10-2. https://doi.org/10.5694/j.1326-5377.2005.tb06879.x
- Fakih MG, Trump DL, Muindi JR, Black JD, Bernardi RJ, Creaven PJ, et al. A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors. Clin Cancer Res 2007;13:1216-23. https://doi.org/10.1158/1078-0432.CCR-06-1165